Upping our game when documenting adverse reactions.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 31, doi. 10.1002/psb.2020
- Publication type:
- Article
Works matching IS 09596682 AND DT 2022 AND VI 33 AND IP 10
Results: 8
1
2
Ponesimod for the treatment of relapsing multiple sclerosis.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 29, doi. 10.1002/psb.2019
- Publication type:
- Article
3
Cenobamate for focal‐onset seizures in resistant epilepsy.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 27, doi. 10.1002/psb.2018
- Publication type:
- Article
4
Updated guideline on managing depression in adults.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 23, doi. 10.1002/psb.2017
- Publication type:
- Article
5
Autoimmune diseases: the immunological tightrope.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 19, doi. 10.1002/psb.2016
- Publication type:
- Article
6
Prescribing Skills Assessment.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 18, doi. 10.1002/psb.2015
- Publication type:
- Article
7
Emerging roles of sodium‐glucose co‐transporter inhibitors.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 11, doi. 10.1002/psb.2014
- Publication type:
- Article
8
Neurological diseases: optimism for the future.
- Published in:
- Prescriber, 2022, v. 33, n. 10, p. 4, doi. 10.1002/psb.2013
- Publication type:
- Article